 NEW YORK, Aug. 12, 2021 PRNewswire -- DarioHealth Corp. Nasdaq: DRIO, a pioneer in the global digital therapeutics market, today announced a new study at the American Association of Diabetes Care and Education Specialists ADCES annual conference demonstrating the impact of Darios intelligent personalization platform. Darios latest presentation examined the impact of personalized clinical interventions delivered in real-time through the companys digital therapeutics platform. 